Infectious Diseases News and Research

RSS

Flusurvey: an interview with Dr Alma Adler

Flusurvey is an online system of tracking influenza across the UK. We are linked to other flu surveys across Europe, so there are about 12 flu surveys across Europe in total.

9 Jan 2013

Sublingual immunotherapy can effectively treat peanut allergy

Peanuts are one of the most common triggers of severe food-induced allergic reactions, which can be fatal, and the prevalence of peanut allergy is increasing. However, there is currently no clinical treatment available for peanut allergy other than strict dietary elimination and, in cases of accidental ingestion, injections of epinephrine.

9 Jan 2013

SNSF-funded professor to receive 2012 National Latsis Prize

On 10 January 2013, Jacques Fellay will receive the National Latsis Prize 2012 at the Rathaus in Berne. The Swiss National Science Foundation (SNSF) is awarding the Prize to the SNSF-funded professor at EPF Lausanne in recognition of his work on the human genome and its defence mechanisms against viral diseases such as AIDS.

8 Jan 2013

Extended involvement maximizes gains from rapid response teams

An intensivist-led, multidisciplinary rapid-response team with extended involvement in patient care yields multiple benefits, say researchers.

8 Jan 2013

Adolescents may lose hepatitis B virus protection despite vaccination as infants

New research reveals that a significant number of adolescents lose their protection from hepatitis B virus (HBV) infection, despite having received a complete vaccination series as infants. Results in the January 2013 issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, suggest teens with high-risk mothers (those positive for HBeAg) and teens whose immune system fails to remember a previous viral exposure (immunological memory) are behind HBV reinfection.

8 Jan 2013

Benefits of respiratory treatment for extremely premature infants persist

There are no significant differences in death or neurodevelopmental impairment between toddlers who underwent early continuous positive airway pressure or early surfactant administration as extremely premature infants, research shows.

7 Jan 2013

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

7 Jan 2013

Researchers show that protein p62 balances metabolism in fat tissue

In many cases, obesity is caused by more than just overeating and a lack of exercise. Something in the body goes haywire, causing it to store more fat and burn less energy. But what is it? Researchers at Sanford-Burnham Medical Research Institute have a new theory-a protein called p62.

7 Jan 2013

Raising transfusion threshold improves acute upper GI bleeding outcomes

Outcomes among patients with acute upper gastrointestinal bleeding can be improved by employing a restrictive transfusion strategy that raises the threshold for the transfusion of red cells, the results of a Spanish study indicate.

4 Jan 2013

Killing of polio workers in Pakistan is major setback for global elimination drive

"The brutal assassination of nine grassroots level health workers in Pakistan, who were involved in a door-to-door immunization campaign in an attempt to secure children from crippling polio, adds an unprecedentedly grave dimension to the ongoing carnage in Pakistan," Sania Nishtar, founder of Heartfile, Heartfile Health Financing, and the recently launched Sania Nishtar Health Fund, writes in an opinion piece in the Huffington Post U.K.'s "Impact" blog.

4 Jan 2013

Paratek receives FDA QIDP designation for omadacycline to treat ABSSSI, CABP

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

3 Jan 2013

Trovagene, MD Anderson partner to detect transrenal BRAF mutations in metastatic cancers

Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.

3 Jan 2013

Sexual revolution effect may be hiding true extent of HPV prevalence

Human papillomavirus infection in older women is commonly due to reactivation of latent disease rather than new infection, research indicates.

2 Jan 2013

Inpatient mortality increased by emergency department overcrowding

Periods of high crowding at emergency departments have a detrimental impact on outcomes, with increased patient mortality, length of hospital stay, and healthcare costs for admitted patients, US study findings indicate.

2 Jan 2013

Pediatric caustic ingestion injuries ‘much lower than believed’

The public health burden associated with children swallowing caustic chemicals is less than widely believed, US researchers report in the Archives of Otolaryngology - Head and Neck Surgery.

2 Jan 2013

Soligenix's OrbeShield granted FDA oral BDP orphan drug designation

Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.

2 Jan 2013